Table 1: Baseline clinical characteristics of 21 patients with LDL apheresis.

Age, years
Female3 (14.3%)
BMI, kg/m2
Hypertension11 (52%)
Diabetes4 (19%)
Smoking5 (24%)

Previous conditions
Myocardial infarction6 (29%)
Coronary artery bypass grafting10 (48%)
PCI angioplasty5 (24%)

Medications
Beta-blockers12 (57%)
ACE inhibitors0 (0%)
Nitrates2 (10%)
Calcium-channel blockers6 (56%)
Statins19 (90%)
Fibrates7 (33%)
Colesevelam14 (67%)
Ezetimibe10 (48%)
Aspirin10 (48%)
Clopidogrel5 (24%)
Acenocoumarin2 (10%)
LDL apheresis period, months
LDL cholesterol before entry  mmol/l (  mg/dL)

LDL indicates low-density lipoprotein, PCI indicates percutaneous coronary intervention, and ACE indicates angiotensin-converting enzyme. Values were expressed as means ± standard deviation (SD); other values were numbers of patients with percentages given in parentheses.